Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Technology Advances: CISH technology Facilitates Assay of HER2 Expression
Dorothy J. Schirf, MD, MDLinx Oncology
Today's Oncology News: VEGFb Designated Orphan Drug Status By FDA
D Scott Cunningham MD, PhD, MDLinx Oncology
  See all
hepatocellular carcinoma;chromosome 5Q34 Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma
Journal of Cancer Research & Clinical Oncology, 05/14/08
Print     Email This Article     Save in My Library   Free Abstract
Saelee P et al. - In a trial to identify and characterize novel genetic alterations in hepatocellular carcinoma (HCC), it seems that allelic loss on chromosome 5q34 may be involved in development of HCC and could be used as a prognostic indicator in HCC pts

Methods
  • DNA was extracted from 29 HCC and corresponding normal tissues and amplified with 59 different 10-base arbitrary primers
  • A 550 bp DNA fragment amplified using primer Q-9 and which was present in 19 of 29 cases was cloned, sequenced, and compared with known nucleotide sequences deposited in Genome database, and quantified by real-time PCR

Results
  • DNA alterations were found on chromosomes 5q34, 6p25.2, and 8q12.1 in 11 of 29 cases, 7 of 29 cases, and 12 of 29 cases, respectively
  • Multivariate analysis showed that allelic loss on chromosome 5q34 was an independent prognostic factor for poor survival of HCC pts, with the median survival time of 19 weeks for allelic loss vs 109 weeks for no allelic loss

 

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

Sponsor
--- HEPATOBILIARY/PANCREAS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.